2025-525042-22-00RecruitingPhase 1
A Study to Evaluate the Safety and Activity of an Inhaled Investigational Drug (RO7616605) in Healthy Volunteers and Participants With COPD
Source: EU CTIS (euclinicaltrials.eu) · Last updated 24 Aug 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 104 (estimated)
- First submitted
- 12 May 2026
- Start date
- 27 Aug 2026
- Lead sponsor
- Genentech Inc.
- Diseases
- COPD
- EU CT number
- 2025-525042-22-00
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 104
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
AI-kivonat: who the study is looking for
Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for healthy volunteers and people with COPD to test the safety and activity of an inhaled investigational drug, RO7616605.
- Age
- 18 years or older
- Sex
- All sexes can join.
Read by machine on 9 Nov 2026.
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Charite Research Organisation GmbH | Berlin | Germany | Recruiting |
| The Fraunhofer Institute For Toxicology And Experimental Medicine ITEM | Hanover | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.